EGFR signaling plays a central role in cell proliferation and survival [22,23], and aberrant activation of EGFR is known to be a major oncogenic pathway for progression and metastasis of many cancers [24,25,26,27] including SCC [28,29]. Here, EGFR is linked to cancer.